Mr. Alberto S. Pappo M.D.
Hematologist (Pediatric) | Pediatric Hematology-Oncology
6701 Fannin St Houston TX, 77030About
Dr. Alberto Pappo is a pediatric hematologist practicing in Houston, TX. Dr. Pappo specializes in treating children that have a blood disease or cancer. Such blood diseases include disorders of red blood cells, white blood cells and/or platelets. The types of cancers that Dr. Pappo treats include leukemias, lymphomas and certain tumors. Dr. Pappo can also treat bleeding disorders in children. Pediatric hematologists can be found in childrens hospitals, community hospitals, university medical centers and more.
Education and Training
Universidad Anahuac Escuela De Medicina, Mexico MD
Universidad Anahuac Escuela De Medicina, Mexico 1984
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Phase I targeted systemic exposure study of paclitaxel in children with refractory acute leukemias.
- Interpatient variability in bioavailability of the intravenous formulation of topotecan given orally to children with recurrent solid tumors.
- Soft-tissue malignancies in infancy.
- Brain metastases in pediatric Ewing sarcoma and rhabdomyosarcoma: the St. Jude Children's Research Hospital experience.
- Role of adjuvant chemotherapy in the treatment of surgically resected pediatric nonrhabdomyosarcomatous soft tissue sarcomas: A Pediatric Oncology Group Study.
- Prognostic factors for children and adolescents with surgically resected nonrhabdomyosarcoma soft tissue sarcoma: an analysis of 121 patients treated at St Jude Children's Research Hospital.
- Clear cell sarcoma of soft tissues in children and young adults: the St. Jude Children's Research Hospital experience.
- Hemangiopericytoma in children and infants.
- Hematologic abnormalities and acute myeloid leukemia in children and adolescents administered intensified chemotherapy for the Ewing sarcoma family of tumors.
- Childhood carcinoid tumors: the St Jude Children's Research Hospital experience.
- Cyclophosphamide and etoposide for pediatric solid tumors.
- Carboplatin/ifosfamide window therapy for osteosarcoma: results of the St Jude Children's Research Hospital OS-91 trial.
- Up-front window trial of topotecan in previously untreated children and adolescents with metastatic rhabdomyosarcoma: an intergroup rhabdomyosarcoma study.
- Selective use of whole-lung irradiation for patients with Ewing sarcoma family tumors and pulmonary metastases at the time of diagnosis.
- Use of reverse transcriptase polymerase chain reaction for diagnosis and staging of alveolar rhabdomyosarcoma, Ewing sarcoma family of tumors, and desmoplastic small round cell tumor.
Clinical Trials
- Tumor Rebiopsy in Children and Adolescents With Recurrent or Progressive Solid Malignancies
- Molecular Analysis of Childhood and Adolescent Melanocytic Lesions
- Preservation of Ovarian Tissue and Chemo-Radiotherapy
- Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors
- Phase I Study of LDK378 in Pediatric, Malignancies With a Genetic Alteration in Anaplastic Lymphoma Kinase (ALK)
- Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)
- Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)
- Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
- Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)
- Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
- Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
- Selumetinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
- PI3K/mTOR Inhibitor LY3023414 in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)
Mr. Alberto S. Pappo M.D.'s Practice location
Mr. Alberto S. Pappo M.D.'s reviews
Write ReviewPatient Experience with Dr. Pappo
Recommended Articles
- What Are Submucosal Leiomyomas?
Submucosal leiomyomas are non-cancerous tumors occurring at the wall of the uterus. It’s common in women of childbearing age. Most women with fibroids might not experience any visible symptoms. For some women, the symptoms of submucosal fibroids could become so severe that they interfere with...
- What is Lupus?
Lupus is an inflammatory chronic disease that develops when the body immune system attacks and damages its own organs and tissues. Inflammation as a result of lupus can damage different body systems such as the blood cells, brain, joints, skin, lungs, heart and kidneys.The normal and main function...
- Purpura
PurpuraPurpura refers to purple-colored spots that are usually seen on the skin, including mucous membranes and other organs. It is also called skin hemorrhages or blood spots.Purpura is usually recognized when there is pooling of blood under the skin due to ruptured small blood vessels. The size of...
- Study Finds 3% of Pediatric Non-Hodgkin Lymphoma Cases Are Transplant Recipients
Lymphoma is a blood cancer that affects both children and adults.Lymphoma begins its growth in the lymphatic white blood cells of the lymph system. This system is a major warrior in fighting off infections and diseases. It is part of the body’s immunity team.The lymph system loops throughout the...
- How Is Leukemia Diagnosed?
Leukemia in its early stages may present no signs or symptoms, as these only appear when the leukemia cells have taken over a large number of normal blood cells. A person with leukemia is very lucky indeed if early-stage detection occurs incidentally, through a routine blood test or one done for...
- Potential Causes of Leukopenia
IntroductionA decrease in the number of white blood cells (WBCs) is referred to as leukopenia. There are several causes for leukopenia. It may be due to certain drugs, cancer, radiation and chemotherapy for cancer, stem cell transplant, surgery, steroids, or autoimmune disorders. The immune system...
Nearby Providers
- Dr. Parth Mehta M.D.1102 Bates Ave Houston TX 77030
- Dr. Ching Ching Lau MD, PHD6701 Fannin St Houston TX 77030
- Dr. Susan Blaney MD6701 Fannin St Houston TX 77030
- Dr. Mehmet Okcu MD6701 Fannin St Houston TX 77030
- Dr. Patrick A Thompson MD6701 Fannin St Houston TX 77030
- Dr. Carl E Allen MD6701 Fannin St Houston TX 77030